These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34731882)

  • 1. Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.
    Teraz-Orosz A; Gierula M; Petri A; Jones D; Keniyopoullos R; Folgado PB; Santamaria S; Crawley JTB; Lane DA; Ahnström J
    Blood Adv; 2022 Jan; 6(2):704-715. PubMed ID: 34731882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.
    Somajo S; Ahnström J; Fernandez-Recio J; Gierula M; Villoutreix BO; Dahlbäck B
    Thromb Haemost; 2015 May; 113(5):976-87. PubMed ID: 25716664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.
    Dahlbäck B
    J Thromb Haemost; 2017 Jul; 15(7):1241-1250. PubMed ID: 28671348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.
    Reglińska-Matveyev N; Andersson HM; Rezende SM; Dahlbäck B; Crawley JT; Lane DA; Ahnström J
    Blood; 2014 Jun; 123(25):3979-87. PubMed ID: 24740810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preAR2 region (1458-1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα.
    Dahlbäck B; Tran S
    J Thromb Haemost; 2022 Jan; 20(1):58-68. PubMed ID: 34623729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
    Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
    J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S.
    Dahlbäck B; Tran S
    J Thromb Haemost; 2022 May; 20(5):1146-1157. PubMed ID: 35247027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short.
    Dahlbäck B; Guo LJ; Zöller B; Tran S
    J Thromb Haemost; 2019 Apr; 17(4):585-595. PubMed ID: 30740865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
    Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
    J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S.
    Ahnström J; Andersson HM; Hockey V; Meng Y; McKinnon TA; Hamuro T; Crawley JT; Lane DA
    Blood; 2012 Dec; 120(25):5059-62. PubMed ID: 23074276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma.
    Alshaikh NA; Rosing J; Thomassen MCLGD; Castoldi E; Simioni P; Hackeng TM
    J Thromb Haemost; 2017 May; 15(5):950-960. PubMed ID: 28211163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.
    van Doorn P; Rosing J; Duckers C; Hackeng TM; Simioni P; Castoldi E
    Thromb Haemost; 2018 Jul; 118(7):1194-1202. PubMed ID: 29864781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein S K196E mutation reduces its cofactor activity for APC but not for TFPI.
    Maruyama K; Akiyama M; Miyata T; Kokame K
    Res Pract Thromb Haemost; 2018 Oct; 2(4):751-756. PubMed ID: 30349894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFPI-dependent activities of protein S.
    Peraramelli S; Rosing J; Hackeng TM
    Thromb Res; 2012 May; 129 Suppl 2():S23-6. PubMed ID: 22425215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
    Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
    Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein S is a cofactor for tissue factor pathway inhibitor.
    Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM
    Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminus of tissue factor pathway inhibitor-α inhibits factor V activation by protecting the Arg
    van Doorn P; Rosing J; Wielders SJ; Hackeng TM; Castoldi E
    J Thromb Haemost; 2017 Jan; 15(1):140-149. PubMed ID: 27801970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TFPIα C-terminal tail is essential for TFPIα-FV-short-protein S complex formation and synergistic enhancement of TFPIα.
    Gierula M; Noakes VM; Salles-Crawley II; Crawley JTB; Ahnström J
    J Thromb Haemost; 2023 Dec; 21(12):3568-3580. PubMed ID: 37739040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding site for C4b-binding protein in vitamin K-dependent protein S fully contained in carboxy-terminal laminin-G-type repeats. A study using recombinant factor IX-protein S chimeras and surface plasmon resonance.
    He X; Shen L; Malmborg AC; Smith KJ; Dahlback B; Linse S
    Biochemistry; 1997 Mar; 36(12):3745-54. PubMed ID: 9132028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.